Bsx nyse.
The public float for BSX is 1.46B, and at present, short sellers hold a 0.63% of that float. On November 17, 2023, the average trading volume of BSX was 8.51M shares. BSX) stock’s latest price update. Boston Scientific Corp. (NYSE: BSX) has seen a rise in its stock price by 1.52 in relation to its previous close of 53.85.
Veja a previsão de preço das ações da Boston Scientific Corporation para 1 ano, feita pelos analistas e compare-a com as mudanças de preço ao longo do tempo para desenvolver uma melhor estratégia de negociação.Boston Scientific Corp. analyst ratings, historical stock prices, earnings estimates & actuals. BSX updated stock price target summary.Boston Scientific Corp. (NYSE:BSX) trade information. Instantly BSX was in green as seen at the end of in last trading. With action 2.41%, the performance over the past five days has been green. The jump to weekly highs of 55.35 on Tuesday, 11/21/23 added 1.58% to the stock’s daily price.Nov 28, 2023 · 9. Boston Scientific Corporation (NYSE:BSX) Number of Hedge Fund Holders: 69 . Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices. Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...
Apr 30, 2022 · Bermuda Stock Exchange - BSX: The stock exchange headquartered in Hamilton, Bermuda.
Stock analysis for Boston Scientific Corp (BSX:New York) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Real-time Price Updates for Boston Scientific Corp (BSX-N), along with buy or sell indicators, analysis, charts, historical performance, news and moreWebDuring the last session, Boston Scientific Corp. (NYSE:BSX)’s traded shares were 7.46 million, with the beta value of the company hitting 0.77. At the end of the trading day, the stock’s price was $51.56, reflecting an intraday gain of 0.25% or $0.13. The 52-week high for the BSX share is $55.38 ...Find the latest Blackstone Minerals Limited (BSX.AX) stock quote, history, news and other vital information to help you with your stock trading and investing.Apr 24, 2023 · Boston Scientific ( NYSE: BSX) and Shockwave Medical ( NASDAQ: SWAV) traded flat in the pre-market Monday as UBS said that a potential buyout deal between the two companies was unlikely, contrary ...
Nov 28, 2023 · 9. Boston Scientific Corporation (NYSE:BSX) Number of Hedge Fund Holders: 69 . Boston Scientific Corporation (NYSE:BSX) makes and sells medical devices.
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.079 = US$2.3b ÷ (US$34b - US$4.6b) (Based on the trailing twelve months to September ...Web
For the full year, Boston Scientific Corporation (NYSE:BSX) lowered its adjusted earnings outlook to a range of $1.71 – $1.74 per share, from its previous guidance between $1.74 – $1.77 per share.Rock Springs Capital Management LP acquired a new position in shares of Boston Scientific Co. (NYSE:BSX - Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 267,500 shares of the meBoston Scientific Corporation (NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany Participants. Lauren Tengler - Vice President, Investor Relations. Mike Mahoney ...Boston Scientific Corporation (BSX) NYSE - Nasdaq Real Time Price. Currency in USD Follow 2W 10W 9M 55.88 -0.01 (-0.03%) As of 02:28PM EST. Market open. 1d 5d 1m 6m YTD 1y 5y Max Full screenBoston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX 0.0% saw its stock ...Boston Scientific Corporation (NYSE:BSX) entered into a definitive merger agreement to acquire Apollo Endosurgery, Inc. (NasdaqGM:APEN) for approximately $440 million. Nov 30 Boston Scientific Corporation Announces the First Results from the ACURATE neo2 Post Market Clinical Follow-up (PMCF) StudyDec 4, 2023 · Boston Scientific last released its quarterly earnings results on October 26th, 2023. The medical equipment provider reported $0.50 earnings per share for the quarter, beating analysts' consensus estimates of $0.48 by $0.02. The company earned $3.53 billion during the quarter, compared to the consensus estimate of $3.48 billion.
08 Mar, 2022, 16:30 ET. MARLBOROUGH, Mass., March 8, 2022 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) (the "Company") today announced that American Medical Systems Europe B.V., its ...Mount Lucas Management LP bought a new position in Boston Scientific Co. (NYSE:BSX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC.The ...On October 27, investment advisory Canaccord maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) stock and lowered the price target to $60 from $64, appreciating the strong ...BSX:FRA. Select symbol. United States; BSX:NYQNYSE · BSX:NYSNYSE · BSX:ASENYSE American; Germany; BSX:BERBerlin Stock Exchange · BSX:DUSDusseldorf Stock ...Apr 26, 2023 · 26 Apr, 2023, 06:30 ET. MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing ...
26 Apr, 2023, 06:30 ET. MARLBOROUGH, Mass., April 26, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing ...
9 Nov 2023 ... Boston Scientific (NYSE: BSX) reported its Q3 results last month, with revenues and earnings beating the street estimates.MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the fourth quarter of 2022, growing 3.7 percent on a reported basis, 8.7 percent on an operational 1 basis and 7.1 percent on an organic 2 basis, all compared to the prior year period.Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.389 billion during the first quarter of 2023, growing 12.0 percent on a reported basis, 14.9 percent on an operational1 basis ...Feb 2, 2022 · MARLBOROUGH, Mass., Feb. 2, 2022 / PRNewswire / -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.127 billion during the fourth quarter of 2021, growing 15.4 percent on a reported basis, 16.9 percent on an operational 1 basis and 15.1 percent on an organic 2 basis, all compared to the prior year period. Mount Lucas Management LP bought a new position in Boston Scientific Co. ( NYSE:BSX – Free Report) in the 2nd quarter, according to the company in its most recent filing with the SEC. The ...1. Confirmed cup and handle pattern on BSX chart Hi, please see the following chart pattern, that has been confirmed in the last weeks. Accordingly to the rules of the pattern, the price target is about 70$. If doesn't will come a market crash, there is a good opportunity, to reach the TP. The price action is supported with the AI hype, that is ...
Find real-time BSX - Boston Scientific Corp stock quotes, company profile, news and forecasts from CNN Business.
Bloomberg News reported on April 21 that Boston Scientific, which has a market value of about $77 billion, may buy Shockwave Medical, a maker of artery-clearing devices with a market capitalization of about $10 billion. The report cited people familiar with the matter. With $570 million in cash on hand at the end of March, according to a …Web
Each major bond market around the world has its own closing hours, but the New York Stock Exchange (NYSE) closes at 4:30 p.m. EST, according to the Financial Web. Bond trading begins on the NYSE at 9:30 a.m. EST.ANET Stock, BSX, LULU, ZS And 10 Other Tickers Pop Onto IBD Watchlists Boston Scientific Reaches 80-Plus Relative Strength Rating Benchmark Boston Scientific Offers Bullish Guidance And Briefly ...About the company. Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. The Company’s segments include MedSurg and Cardiovascular. The MedSurg segment includes Endoscopy and Urology and Neuromodulation. I.Simply Wall St ™. Simply Wall Street Pty Ltd. Level 7, 320 Pitt Street, Sydney. Popular Markets. US AU UK IN CA ZA. Uncover the latest insider trading activity for Boston Scientific Corporation (BSX). Know which insiders are buying and selling along with top shareholders and ownership breakdown.Boston Scientific Corporation (NYSE:BSX) Q4 2022 Results Conference Call February 1, 2023 8:00 AM ETCompany Participants. Lauren Tengler - Vice President, Investor Relations. Mike Mahoney ...WebNov 30, 2023 · View Boston Scientific Corporation BSX investment & stock information. Get the latest Boston Scientific Corporation BSX detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Nov 30, 2023 · View real-time BSX stock price and news, along with industry-best analysis. ... Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE ... Boston Scientific stock (NYSE: BSX) currently trades at $51 per share, roughly 30% above its level in March 2021, and it now seems to be fully valued. Boston Scientific BSX 0.0% saw its stock ...MARLBOROUGH, Mass., May 20, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting use of the company's key electrophysiology and cardiac rhythm management ...Bloomberg News reported on April 21 that Boston Scientific, which has a market value of about $77 billion, may buy Shockwave Medical, a maker of artery-clearing devices with a market capitalization of about $10 billion. The report cited people familiar with the matter. With $570 million in cash on hand at the end of March, according to a …Web
Oct 19, 2023 · On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ... On July 24, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $52.17 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -2.49%, and its shares gained 37.29% ...Their BSX share price targets range from $55.00 to $66.00. On average, they anticipate the company's share price to reach $60.55 in the next year. This suggests a possible upside of 8.7% from the stock's current price. View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.Boston Scientific Corporation (NYSE:BSX), known for its innovative stent technology in heart surgery, ... Financially, BSX shows strong growth with net sales of a robust $3.52 billion, an 11.2% ...WebInstagram:https://instagram. biv vanguardvalue kennedy half dollar 1964tips bond etftreasury i bonds rate BSX Stock 12 Months Forecast. $60.95. (9.94% Upside) Based on 21 Wall Street analysts offering 12 month price targets for Boston Scientific in the last 3 months. The average price target is $60.95 with a high forecast of $67.00 and a low forecast of $58.00. The average price target represents a 9.94% change from the last price of $55.44. On October 18, 2023, Boston Scientific Corporation (NYSE:BSX) stock closed at $50.71 per share. One-month return of Boston Scientific Corporation (NYSE:BSX) was -5.82%, and its shares gained 26.35 ... rolls royce stock pricehow to invest in instacart Boston Scientific (NYSE: BSX) is scheduled to report its Q1 2023 results on Wednesday, April 26. We expect the company to report revenues and earnings in line with the consensus estimates. anhauser bush stock Boston Scientific Corporation. 01 Feb, 2023, 06:30 ET. MARLBOROUGH, Mass., Feb. 1, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.242 billion during the ...Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Urology and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions.